| abstract |
The present disclosure generally relates to substantially hydrophobic acids and therapeutic agents (1- (4-{[4- (dimethylamino) piperidin-1-yl] carbonyl} phenyl) -3- [4- (4,6 -Dimorpholin-4-yl-1,3,5-triazin-2-yl) phenyl] urea) or a pharmaceutically acceptable salt thereof and a polymer. Other embodiments include methods for making and using such nanoparticles. |